BG
AUTL

Bellevue Group’s Autolus Therapeutics AUTL Stock Holding History

Bellevue Group’s Portfolio AUTL Stock Details AUTL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$97.5K Hold
2024
Q3 		$151K Buy
2024
Q2 		$113K Hold
2024
Q1 		$207K Sell
2023
Q4 		$322K Buy
2020
Q1 		– Sell
2019
Q4 		$821K Buy
2019
Q3 		$430K Buy
2019
Q2 		$547K Buy